Cambridge, MA¸ January 02, 2024 (Reuters) -- Voyager Therapeutics (VYGR.O) announced a strategic collaboration with the Swiss-based pharmaceutical company Novartis (NOVN.S). Under this licensing agreement, Novartis will make an upfront payment of $100 million to Voyager. Additionally, Voyager stands to receive up to $1.2 billion upon reaching specific milestones.
Read full article here.
NY, NY, April 18, 2024 (Business Wire) -- Metsera, Inc., a pioneering player in the clinical-stage biopharmaceutical realm focusing on innovative treatments for obesity and metabolic ailments, has e
Cambridge, MA, April 23 2024 (PRNewswire) -- Flare Therapeutics Inc. has undergone a notable leadership transition with the selection of Dr. Douglas Manion, M.D., FRCP (C), as its newly appointed Ch
Wilmington, DE, April 23, 2024 (RTTNews) -- Incyte Corp. (INCY) is buying Escient Pharmaceuticals and its assets for $750 million, plus any cash left over when the deal closes. This acquisition need
